Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp.
AbstractKiamycin (1), a new angucyclinone derivative possessing an 1,12-epoxybenz[a]anthracene ring system, was isolated from the marine Streptomyces sp. strain M268 along with the known compounds 8-O-methyltetrangomycin (3) and 8-O-methylrabelomycin (4). Their structures were elucidated by detailed spectroscopic analysis and comparison with literature data. The new angucyclinone derivative showed inhibitory activities against the human cell lines HL-60 (leukemia), A549 (lung adenocarcinoma), and BEL-7402 (hepatoma) with inhibition rates of 68.2%, 55.9%, and 31.7%, respectively, at 100 µM. It appears to have potential as an anticancer agent with selective activity.
- Supplementary File 1:
ZIP-Document (ZIP, 602 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Xie, Z.; Liu, B.; Wang, H.; Yang, S.; Zhang, H.; Wang, Y.; Ji, N.; Qin, S.; Laatsch, H. Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp.. Mar. Drugs 2012, 10, 551-558.
Xie Z, Liu B, Wang H, Yang S, Zhang H, Wang Y, Ji N, Qin S, Laatsch H. Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp.. Marine Drugs. 2012; 10(3):551-558.Chicago/Turabian Style
Xie, Zeping; Liu, Bing; Wang, Hongpeng; Yang, Shengxiang; Zhang, Hongyu; Wang, Yipeng; Ji, Naiyun; Qin, Song; Laatsch, Hartmut. 2012. "Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp.." Mar. Drugs 10, no. 3: 551-558.